Edwards gets conditional OK for U.S. trial of replacement heart valve

09/24/2010 | Forbes · Nasdaq.com

Edwards Lifesciences said it has been granted conditional approval by the FDA to conduct the first of the two clinical trials of its Sapien XT transcatheter heart valve in patients suffering from severe symptomatic aortic stenosis. The device was approved by European regulators in March.

View Full Article in:

Forbes · Nasdaq.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN